Perrigo Establishes Tax Base in $8.6B Elan Deal
July 29 (Bloomberg) -- Bloomberg News' Matthew Campbell reports that Perrigo Co. has come to an agreement to buy Irish drug company Elan Corp. for $8.6 billion, establishing a low-tax base for international expansion. He speaks on Bloomberg Television's "The Pulse."
Most Recent Videos
Oil Hovers Near Two-Month Lows on Weight of Fundamentals
33:23 - In today's "Futures in Focus," Alan Knuckman of Bulls-Eye Options and Bloomberg's Alix Steel examine oil market fundamentals. They speak on "Bloomberg ‹GO›." (Source: Bloomberg)